Finance

Lists
Q3 2026 earnings • released • EPS beat +၁၆.၀၉% • Revenue beat +၂.၇၉%
See results
PACB:NASDAQ
Pacific Biosciences of California Inc
၂.၂၆ US$
-၇.၂၀%
(-၀.၁၇) 1D
၂.၂၅ US$
-၀.၁၄% (-၀.၀၀၃၂)
After hours
Closed: နို ၆, GMT-၅ ၁၆:၀၀:၀၀  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PACB...
Open
၂.၄၃ US$
High
၂.၅၄ US$
Low
၂.၂၄ US$
Mkt. cap
၇၀.၀၉ ကုဋေ
Avg. vol.
၁.၉၀ ကုဋေ
Volume
၉.၅၆ သန်း
52-wk high
၃.၄၄ US$
52-wk low
၁.၀၇ US$
EPS
-၀.၄၃ US$
Beta
၂.၂၁
Shares outstanding
၃၁.၀၈ ကုဋေ
No. of employees
၄၈၅
Open
၂.၄၃ US$
High
၂.၅၄ US$
Low
၂.၂၄ US$
Mkt. cap
၇၀.၀၉ ကုဋေ
Avg. vol.
၁.၉၀ ကုဋေ
Volume
၉.၅၆ သန်း
52-wk high
၃.၄၄ US$
52-wk low
၁.၀၇ US$
EPS
-၀.၄၃ US$
Beta
၂.၂၁
Shares outstanding
၃၁.၀၈ ကုဋေ
No. of employees
၄၈၅
News stories
From web sources and news partners
TradingView
TradingView
·
ပြီးခဲ့သည့် ၂ ရက်
Key facts: PACB Q3 Revenue Rises 6%; Barclays and Piper Sandler Raise Price Targets
Yahoo Finance Singapore
Yahoo Finance Singapore
·
ပြီးခဲ့သည့် ၂ ရက်
Pacific Biosciences of California Inc (PACB) (Q3 2026) Earnings Call Highlights: Revenue Grows ...
GuruFocus
GuruFocus
·
ပြီးခဲ့သည့် ၂ ရက်
PACB Reiterated by Piper Sandler -- Price Target Raised to $3.00
Profile
Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing, based on the properties of zero-mode waveguides and sequencing by binding chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension. Wikipedia
About Pacific Biosciences of California Inc
CEOChristian Henry
Employees၄၈၅
Founded၂၀၀၄
HeadquartersMenlo Park, ကယ်လီဖိုးနီးယားပြည်နယ်, ယူနိုက်တက်စတိတ်
SectorHealth Care
Industry-
Websitepacb.com
Analyst ratings
Based on 5 analysts giving stock ratings to PACB in the past 3 months
Hold
Buy
2
Hold
2
Sell
1
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for PACB in the last 3 months.
Highest
Current ၂.၂၆ US$
၃.၀၀ US$ (+၃၃.၀၄%)
Average
၂.၃၇ US$ (+၅.၁၀%)
Lowest
၁.၃၅ US$ (-၄၀.၁၃%)
Analyst
Recommendation
Action
Price target
Projected
Date
Kyle Mikson CFA
Canaccord Genuity
Buy
Maintained
၃.၀၀ US$
+၃၃%
11/05/2026
David Westenberg
Piper Sandler
Hold
Reiterated
၃.၀၀ US$
+၃၃%
11/05/2026
Luke Sergott
Barclays
Sell
Maintained
၂.၀၀ US$
-၁၁.၃%
11/05/2026
Mason Carrico
Stephens
Buy
Maintained
၂.၅၀ US$
+၁၀.၉%
10/23/2026
Unknown Analyst
UBS
Hold
Initiated
၁.၃၅ US$
-၄၀.၁%
09/08/2026
Doug Schenkel
UBS
Hold
Maintained
၁.၃၅ US$
-၄၀.၁%
09/09/2026
Daniel Brennan
TD Cowen
Buy
Maintained
၃.၀၀ US$
+၃၃%
08/06/2026
Subbu Nambi
Guggenheim
Hold
Maintained
-
-
02/12/2026
Last report
၂၀၂၆ နို ၄
Fiscal period
Q3 2026
-၀.၁၁ US$ / -၀.၁၃ US$
+၁၆.၀၉%beat
Revenue / Est. (USD)
၄.၀၆ ကုဋေ / ၃.၉၅ ကုဋေ
+၂.၇၉%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
၂၀၂၆ စက်
Revenue
၄.၄၆ ကုဋေ
၃.၇၂ ကုဋေ
၃.၉၀ ကုဋေ
၄.၀၆ ကုဋေ
Cost of goods sold
၄.၀၃ ကုဋေ
၂.၃၇ ကုဋေ
၂.၆၂ ကုဋေ
၂.၆၆ ကုဋေ
Cost of revenue
၄.၀၃ ကုဋေ
၂.၃၇ ကုဋေ
၂.၆၂ ကုဋေ
၂.၆၆ ကုဋေ
Research and development expenses
၂.၃၅ ကုဋေ
၁.၉၆ ကုဋေ
၂.၃၀ ကုဋေ
၂.၀၂ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၃.၅၈ ကုဋေ
၃.၁၂ ကုဋေ
၃.၃၄ ကုဋေ
၂.၉၄ ကုဋေ
Operating expense
၆.၄၄ ကုဋေ
၅.၁၈ ကုဋေ
၅.၇၄ ကုဋေ
၅.၀၇ ကုဋေ
Total operating expenses
၁၀.၄၇ ကုဋေ
၇.၅၄ ကုဋေ
၈.၃၆ ကုဋေ
၇.၇၃ ကုဋေ
Operating income
-၆.၀၁ ကုဋေ
-၃.၈၃ ကုဋေ
-၄.၄၆ ကုဋေ
-၃.၆၇ ကုဋေ
Other non operating income
၆.၄၈ သန်း
၁.၇၁ သန်း
၂.၀၄ သန်း
၁.၄၈ သန်း
EBT including unusual items
-၄.၀၂ ကုဋေ
-၈.၀၉ သန်း
-၄.၄၇ ကုဋေ
-၃.၇၆ ကုဋေ
EBT excluding unusual items
-၅.၅၃ ကုဋေ
-၃.၈၃ ကုဋေ
-၄.၄၇ ကုဋေ
-၃.၇၃ ကုဋေ
Income tax expense
၂.၀၂ သိန်း
၁.၈၄ သိန်း
၅.၈၀ သောင်း
၂.၆၉ သိန်း
Effective tax rate
-၀.၅၀%
-၂.၂၇%
-၀.၁၃%
-၀.၇၂%
Other operating expenses
၄.၁၈ သန်း
-
-
-
Net income
-၄.၀၄ ကုဋေ
-၈.၂၈ သန်း
-၄.၄၇ ကုဋေ
-၃.၇၈ ကုဋေ
Net profit margin
-၉၀.၄၃%
-၂၂.၂၆%
-၁၁၄.၇၀%
-၉၃.၃၀%
Earnings per share
-၀.၁၂
-၀.၁၂
-၀.၁၄
-၀.၁၁
Interest and investment income
-
-
-
-
Interest expense
-၁.၇၄ သန်း
-၁.၇၄ သန်း
-၂.၁၁ သန်း
-၂.၀၆ သန်း
Net interest expenses
-၁.၇၄ သန်း
-၁.၇၄ သန်း
-၂.၁၁ သန်း
-၂.၀၆ သန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-၅.၆၃ ကုဋေ
-၃.၅၀ ကုဋေ
-၄.၀၈ ကုဋေ
-၃.၂၉ ကုဋေ
Gain or loss from assets sale
-
-၄.၈၁ ကုဋေ
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google အက်ပ်များ